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A B S T R A C T
Objective: To describe self-reported decision-making styles and associated pathways through end-of-life
(EOL) decision-making for African-American, Caucasian, and Hispanic seriously ill male Veterans, and to
examine potential relationships of race/ethnicity on these styles.
Methods: Forty-four African American, White, and Hispanic male Veterans with advanced serious
illnesses participated in 8 racially/ethnically homogenous focus groups. Transcripts were qualitatively
analyzed to identify major themes, with particular attention to themes that might be unique to each of
the racial/ethnic groups.
Results: Patients described two main decision-making styles, deciding for oneself and letting others
decide, leading to ﬁve variants that we labeled Autonomists, Altruists, Authorizers, Absolute Trusters,
and Avoiders. These variants, with exception of avoiders (not found among White patients), were found
across all racial/ethnic groups. The variants suggested different ‘implementation strategies’, i.e., how
clear patients made decisions and whether or not they then effectively communicated them.
Conclusion: These identiﬁed decision-making styles and variants generate strategies for clinicians to
better address individualized advance care planning.
Practice implications: Physicians should elicit seriously ill patients’ decision-making styles and consider
potential implementation strategies these styles may generate, thus tailoring individualized
recommendations to assist patients in their advance care planning. Patient-centered EOL decision-
making can ensure that patient preferences are upheld.
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End-of-life (EOL) decision-making should be based upon
patients’ values, beliefs, and preferences [1]. This standard
emerged from 20th-century medical ethics and health law
strongly emphasizing respect for patient autonomy [2]. However,
focusing exclusively on preferences or their implementation     
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Open access under CC BY-NC-SA license.overlooks a more fundamental aspect of patient autonomy,
respect for the patient’s preferred decision-making style [3]. The
importance of decision-making styles is reﬂected in the literature
on cultural competency, which emphasizes that patients’
preferred EOL decision-making styles can vary [4–7]. Race and
ethnicity can also affect patients’ decision-making style, values,
beliefs, and preferences, and thus impact end-of-life decision-
making [8–12].
Few studies of racially/ethnically diverse patients that examine
EOL decision-making describe patients’ experiences beginning
with their decision-making style and focusing on how patients
then progress in this process, and how EOL decision-making might
vary by race/ethnicity. Physicians need to understand how
patients’ preferred decision-making styles shape their EOL
decision-making, in order to assist them in this difﬁcult task
and to do so in culturally appropriate ways [13,14].
Table 1
Eligible diagnoses for patients.
Non-cancer diagnoses:
 Congestive heart failure with an ejection fraction of <25%, and at least one
hospitalization in prior year as a marker of disease severity
 Chronic obstructive pulmonary disease/emphysema with at least one
previous hospitalization, and on home oxygen therapy
 Chronic liver disease with cirrhosis and ascites
Cancer diagnoses:
 Non-small cell cancer of the lung, Stage III or IV
 Any metastatic solid-tumor cancer
Fig. 1. Flowchart for participant identiﬁcation.
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reported decision-making styles experienced by seriously ill
patients, how these affected their EOL decision-making, and to
generate hypotheses about the relationship of race and ethnicity to
that experience. This approach was open to the discovery of both
commonalities and differences.
2. Methods
2.1. Study sample
After obtaining IRB approval through Baylor College of
Medicine, participants were recruited through the Michael E.
DeBakey VA Medical Center (MEDVAMC) in Houston, Texas. We
identiﬁed and recruited seriously ill patients, using criteria similar
to the SUPPORT (Study to Understand Prognoses and Preferences
for Outcomes and Risks of Treatments) criteria [15], see Table 1.
We screened the electronic medical records of patients who had
ICD-9-codes for one of the target diagnoses and recruited them
through the primary care, geriatrics, and subspecialty clinics
(cardiology, pulmonary, gastrointestinal, and oncology) at MED-
VAMC with permission of their respective physicians. Patients’
physicians were not involved in the recruitment or consenting
process at all other than allowing the research team access to
screen their patients’ electronic charts for eligibility. Patients with
a diagnosis of dementia (per chart review) were excluded.
Potentially eligible patients received a postcard asking for
participation in a group interview session on decision-makingfor advance care planning that included a phone number to opt out.
If they did not opt out, patients were called by trained research
assistants to explain the study, and to obtain preliminary consent
to participate.
Screen-eligible patients were separated in 3 lists: patients likely
to be White, African-American, and Hispanic (per chart review);
race/ethnicity was ultimately determined by self-identiﬁcation.
We aimed to achieve equal participation of all major racial/ethnic
groups represented at our VA through purposive sampling and
oversampling of minority patients. Approximately 30% of patients
listed as White, 50% of patients listed as African-American, and 80%
of patients listed as Hispanic who had been screened as study-
eligible were randomly called and asked to participate.
Fig. 1 shows how the focus groups, each homogenous by race/
ethnicity, were organized. Female, trained, race/ethnicity-concor-
dant moderators with experience in qualitative research con-
ducted the groups. Two of the non-clinician investigators (DE
Table 2
Guiding questions for the patient focus groups.
1. Some people think that it is important for patients to know how likely different types of medical treatment are to bring back their health or even save their life. For
example, for older patients the chance of getting well and leaving the hospital after their heart stops and they have CPR (chest compressions/pumping on the chest) is very,
very small. How important do you think it would be to know about the chances of getting well with different treatments?
Prompts:
For those who say it is important: What are some of the reasons you feel this way?
For those who say it is not important: What are some of the reasons you feel this way?
Is there something else that you think is important?
2. Some people think that it is important for patients to make real detailed, speciﬁc decisions in advance about speciﬁc medical treatments. For example, treatments like
cardiopulmonary resuscitation (chest compressions/pumping on the chest), being put on a breathing machine, or getting food through a tube.
How important do you think it is to make such detailed decisions in advance? [Clarify:] By ‘in advance’ we mean before patients are so sick that they can’t speak for
themselves anymore. This is why some people write down what they want so that there are no doubts about what they want when they can’t speak for themselves
anymore. If you write down what you want this is called a ‘living will’ or ‘advance directive’; if you name someone you would want to make decisions for you when you
can’t decide for yourself, it is called a ‘power of attorney for healthcare’.
Prompts:
For those who say it is important: What are some of the reasons you feel this way?
For those who say it is not important: What are some of the reasons you feel this way?
Is there something else that you think is important?
3. We don’t know very much about what patients themselves think is important about making decisions at the end-of-life.
 What is important to you in making such treatment decisions?
 What things matter most to you when you are very sick?
 What does quality of life regarding your health status mean to you?
 You have had experience with medical procedures, doctors, nurses, and hospitals. How does this inﬂuence your thoughts about the types of treatments you would like to
get at the end-of-life?
 How do you decide for or against certain medical treatments or procedures when a true cure is no longer possible?
[say for illustration purposes:]
For example, when someone has emphysema, there is nothing that will make this lung disease go away, it‘s not like an appendix that can be taken out when it is sick. There
are medications like inhalers that can treat the lung disease, but they don‘t ‘cure’ it. OR: some be operated on or destroyed, not all cancer cells will be killed, and the cancer
can‘t be ‘cured’. [repeat question:] How do you decide for or against certain medical treatments or procedures when a true cure is no longer possible?
 What are your goals for care at the end-of-life?
 How important are religious beliefs or your faith to you when making decisions about medical care?
 Some people want ‘‘everything’’ done and may get a lot more tests and procedures than others.
* What do you think ‘‘everything’’ means?
* Would you want ‘‘everything’’ done even if it caused pain and suffering?
 If you name someone else to make decisions for you when you can‘t do it yourself anymore, how do you know/make sure that that person knows what you would
want?
 Do you think that doctors of your own race/ethnicity explain end-of-life treatments better than other doctors?
* If so, What do you think makes it better and how?
* If not, what do you think makes it worse/the same and how/why?
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Hispanic and African American participants, respectively.
2.2. Focus group procedures
The investigators developed guiding questions after extensive
literature review and pilot-testing of the script through two
patient interviews (Table 2). Moderators made clear at the
beginning of the group session that no one was obliged to answer
any of the questions if they felt uncomfortable. The moderators
made it clear to the participants that they were interested in the
responses of the group, rather than in individual members’
responses. Patients knew they were primarily chosen to participate
in the focus groups because of their individual experiences as a
community of patients. Moderators prompted participants to
elaborate on responses. Comments of other group members also
served as prompts for obtaining additional information about
participants’ experiences [16]. After obtaining informed consent,
focus groups, lasting 65–90 min, were conducted and audio-taped
at MEDVAMC and then transcribed for qualitative analysis. To
ensure conﬁdentiality only codes (no names) were used in the
transcripts and the transcribers were blinded to participants’ race/
ethnicity.
3. Analysis
We conducted inductive qualitative content analysis to identify
ideas and concerns [17,18]. Investigators were racially/ethnically
diverse and had different areas of expertise. Each investigator
independently read transcripts, identiﬁed passages describingvalues or concerns, and assigned codes to subjects’ natural-language
statements, to indicate emerging conceptual categories. We then
compared initial ﬁndings to identify and reconcile differences.
Natural-language statements by patients about their experiences
and decision-making were coded and grouped into conceptual
categories or themes using a consensus-building process among the
investigators. Themes were re-examined for clarity and conciseness.
We used an iterative process of re-reading and recoding passages,
reﬁning coding simultaneously, until ﬁnal consensus was reached.
We selected representative quotes from the transcripts illustrating
ﬁnal categories and themes using ATLAS.ti 5.0.66 (Scientiﬁc
Software Development GmbH, Berlin) to create a coded electronic
data set. We are giving reference to focus group and patient number
after each quote in order to demonstrate that our quotes were
representative of a variety of participants, not just from a select few
who could have potentially been domineering a group.
4. Results
We screened 367 patients and identiﬁed 172 (46.9%) potentially
eligible patients of whom we presumed (per chart review) 94 to be
White, 48 to be African-American, and 30 to be Hispanic. We
randomly called patients from each of these groups (83 total; 35
White, 24 African-American, 24 Hispanic). Of these, 56 (21 White,
16 African American, 19 Hispanic) agreed to participate, and 44
actually participated in one of eight focus groups (see Fig. 1). The
mean age of participants was 57.8 years (Table 3). About 40% of
patients had either a diagnosis of advanced chronic obstructive
pulmonary disease or congestive heart failure, and 11% each had
liver cirrhosis or advanced cancer. All patients except one were
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Fig. 2. A typology of how patients approach decisions about end of life (EOL) care. DM, decision-making; EOL, end-of-life; POA, power of attorney.
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were White and of Mexican origin.
4.1. Preferred decision-making role
Two fundamental decision-making styles emerged: deciding
for oneself or allowing others to decide, with ﬁve important
variants in how patients expressed and justiﬁed these styles
(Fig. 2). These variants, except one, were represented across all
races/ethnicity.
4.2. Deciding for oneself: ‘‘Autonomists’’ and ‘‘Altruists’’
Some participants were adamant about deciding for themselves
(‘‘Autonomists’’): ‘‘That’s my feeling that I think I ought to be able
to dictate how I want it to end, you know’’ (African American
participant #1-1). Among whites, another reason for deciding for
oneself and formalizing this in writing was motivated byTable 3
Characteristics of patients who participated in focus groups.
Characteristics African American (N = 14) 
Mean age (years) 59 
(Range: 55–83 years)
Sex—female 1 
Died within six months of interview 3 
Patient had:
Living will 3 
Durable power of attorney for healthcare 6 
Diagnosis of patient:
Cirrhosis 1 
Chronic obstructive pulmonary disease 7 
Congestive heart failure 4 
Non-small cell lung cancer 2 
Metastatic colon cancer/cholangiocarcinoma 0 discussions about the widely popularized Schiavo case [19].
Autonomists wanted to assure that their wishes would be carried
out: ‘‘I have heard so much about other people being kept on
machines and kept alive and – but they’re not able to speak out and
tell the doctor that they don’t want to be on that machine, but their
loved ones are there and they already told them earlier that they
didn’t want to be, but yet the doctors will keep them on there and
they’ll have to go to court and all this and they’ll go against the
man’s wishes who’s laying there on that machine. And I don’t – I
don’t believe in that at all, you know. That’s the reason I made out a
– me and my wife both had a living will made up and she knows
what I want, and I know what she wants’’ (White participant #3-1).
This belief in a written living will was also echoed in a Hispanic
group ‘‘Put it in writing’’ (#H1-1), ‘‘It has to be written down’’
(#H1-2), and ‘‘You have to write it down as back-up. You know, you
tell them all you want to, but you know at that last minute, because
my daughter’s close to me. I don’t think she’d ever want to let me
go, see’’ (#H1-3). An African American participant (#A2-1) stated:Hispanic (N = 17) Caucasian (N = 13) Total (%) (N = 44)
58.1 56.1 57.8
0 0 1 (2.3%)
1 2 6 (13.6%)
4 5 12 (27.3%)
1 4 11 (25%)
2 2 5 (11.4%)
4 5 16 (36%)
10 4 18 (40.9%)
1 0 3 (6.8%)
0 2 2 (4.5%)
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whether it be greedy or just some of ‘em trying to take control, it
gets hum-drum. Things aren’t really what you want unless it’s
legally done with a will or you have a set power of attorney that has
your wishes recorded and written down.’’ Another patient
explained that a written document was necessary because
surrogates might become incapacitated as well: ‘‘anything can
happen like, uh, wife’s supposed to be taking care of me, but
something could happen to her.’’ . . .‘‘That’s why we have it written
down and designates her as primary – my two kids secondary. So —
somebody there within the family will know what’s going on and
all the instructions be written down. And not open to interpreta-
tion. Verbal communication’s open to a lot of different interpreta-
tions’’ (#W3-2).
A few white patients felt that someone other than family might
do a better job in carrying out a patient’s wishes and thus had
designated medical power of attorneys: ‘‘Well, I think that, naming
a friend as the executor of whatever you want to call this, your
living will or whatever, it creates less friction from certain family
members’’ (#W2-2).
Other participants wanted to avoid burdening others with
decision-making and strove to prevent family discord (‘‘Altruist’’).
Altruists stated: ‘‘And if the time comes when that’s it, just read it
off and take care of it. It shouldn’t be her burden or mine on her
case (#W2-3), ‘‘I don’t want to put no burden on nobody else’’
(#H1-4), and ‘‘I think it’s very important – I don’t want to have my
kids or whatever under that pressure’’ (#A1-2) and: ‘‘it would take
the pressure off the children and the rest of your family because
some of them would be at odds, some of them would want to pull
the plug on you and some of them wouldn’t. [. . .] They wouldn’t
have to go through that if they already know what you want. [. . .]I
feel it’s important for my children to know and not have to, as he
said, be under the pressure to make it.’’ (#A1-2). The patients also
understood discussing EOL care and completing a written living
will as tools for preventing family ﬁghts: ‘‘the will, what my wishes
are, they’ve heard me say it and we have discussed it – not every
one of my children and that’s why I feel like it’s important to write
it out and give each one of them a copy of it (#A1-3), ‘‘I’m afraid I’d
have one of my boys, my daughter or my wife, you know, if I didn’t
tell them anything about my decision, or what it amounts to when
it gets down bad there’s going to be a big family conﬂict over this
one wanting you to live and the other one [. . .] doesn’t want you to
go through this.’’ . . .’’ And I’ve seen it done too many times, where
the families actually, everybody gets separated over one old boy
dying’’ (#W2-1) and: ‘‘They going to start ﬁghting, don’t put them
through it, cut ‘em off. Nope. That’s the reason you prepare your
family. You make your wishes before, a will or something’’ (#H1-
3).
4.3. Letting others decide: ‘‘Authorizers,’’ ‘‘Absolute Trusters,’’ and
‘‘Avoiders’’
Participants who favored letting others decide expressed three
different reasons: trusting others to decide while giving them
guidance (‘‘Authorizers’’); having complete faith in others that
they would know what to do (‘‘Absolute Trusters’’); and letting
others decide as a way of avoiding decision-making, i.e., letting
others decide by default and without giving them guidance
(‘‘Avoiders’’), see Fig. 2.
Authorizers trusted other family members to decide for them
while providing them with general-value guidance or discussing a
few hypothetical scenarios: ‘‘I think it’s very important that
whoever this person is well acquainted with your particular
situation. And you’ve already talked with them and explained or
discussed some of the issues involved to the extent that they know.
They’re not just guessing, they know what’s going to be best foryou.’’ (#A2-2), and ‘‘I prepared them for it and I told them already
and at least, I haven’t written it down, but I got a will and
everything else. But, tell them, I don’t want to, I don’t want no
machines. When I can’t go to the bathroom, you might as well just
pull the plug’’ (#H1-4). If they did not anticipate any family
conﬂict, they felt less need for writing decisions down, e.g., in the
form of a living will: ‘‘ﬁrst my wife and secondly would be my
daughter. Oh, they know. We’ve discussed it. We have discussed it.
Many, many times and they both are together on that. They are not
one of them pulling one way, the other one the other way. They
both agree on everything I want,’’ (#H2-1), or: ‘‘Uh, I don’t have
anything in writing, because when I ask my sisters that’s just like
printing it in gold, stacking it in gold. They’re going to do it (#A2-1).
Absolute Trusters, because of a close relationship, completely
believed in their surrogates’ ability to make the ‘right’ decisions for
them and were agreeable to and accepting of any such decisions
they might make for them. ‘‘I tell my daughter to take care of this.
. . . because I know her very good. Because I just know, that’s it, the
only answer,’’ (#H1-4). ‘‘I tell my wife to speak. My wife, she got the
same power I got. [..] What I, if she thinks is right, she can do it,’’
(#H2-2). Absolute Trusters may not have had prior discussions
with family about EOL care; however, they were at peace with
leaving matters for their family to decide. ‘‘I’ve been married to my
wife for 37 years now and she pretty well knows what I want
done.’’ [Moderator:‘‘How does she know?’’] ‘‘Well, I just know she
does,’’ (#H1-1).
Only two patients represented Avoiders: ‘‘Well, uh, I let them do
whatever the hell they want, because, uh, I really don’t know. I
don’t know what. . . I don’t even know if I want to stay alive at
times, but my wife said that the last time that I was in here, when I
had that heart attack, she asked me afterwards what are we going
to do about your, what do you call that, where you sign, where
somebody make decisions for you?,’’ (#H3-1). Subsequently, this
patient had a discussion with his wife and was able to clarify some
basic values with her, but at the time when he was critically ill, he
had provided no guidance whatsoever to his wife regarding his
wishes and thus he received all potentially life-sustaining
treatments by default. He differed from Absolute Trusters because
he did not say that he felt whatever his wife wanted would be ﬁne;
he just didn’t know what he wanted, and had not thought much
about things. After his wife initiated a conversation with him we
would have considered him an Authorizer.
The other (African American) Avoider did not make any
decisions because he felt it was unnecessary. To him, his or
others’ decisions were irrelevant anyway because all decisions lie
in God’s hands: ‘‘You don’t have no say. The doctors have no say.
Only the master has a say. So, you just wait on it. Just wait,’’ (#A1-
5).
4.4. Race/ethnicity and selected decision-making styles
There was no apparent relation to race/ethnicity in terms of the
two basic decision-making styles or the ﬁve variants. The
exception was the group of Avoiders where we found no white
patient. Among Hispanics, we found a slight dominance of Altruists
and Authorizers. There also seemed to be a slight dominance of
African Americans among Authorizers; many preferred verbal
communication. Whites appeared less skeptical about completing
forms and seemed to have fewer misunderstandings about what
these documents were.
5. Discussion
Our data suggest that patients confronted by EOL decisions will
fall into ﬁve ethically and clinically distinct groups, two based on
deciding for oneself and three based on letting others decide.
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reﬂective of these ﬁve groups (Fig. 2). We examined the
relationship of race/ethnicity to the experience of patients’
decision-making using a purposive sampling strategy to include
equal numbers of African American, white, and Hispanic seriously
ill patients in separate focus groups led by race-concordant
moderators. No previous studies used such a strategy. Additionally,
other studies examining the relationship of race/ethnicity in EOL
decision-making focused mostly on treatment preferences [8,20–
22], and some did not obtain information from patients but used
community samples of older adults who may not have had to face
any EOL decisions [22–24]. We found, except for Avoiders, patients
across all racial/ethnic groups representing the different preferred
decision-making variants. Physicians should not stereotype a
patient into a speciﬁc decision-making variant based on their race/
ethnicity. Moorman et al. examined older adults’ preferences for
autonomy in EOL decision-making and found that the majority
preferred deciding independently, which was associated with
being less avoidant of thoughts of death, not wishing to burden a
caregiver, and being more likely to make a living will and appoint a
medical power of attorney [25].
A fundamental ethical requirement of the principle of respect
for patient autonomy is to identify and empower patients’ self-
selected decision-making styles [3]. Patients who want to decide
for themselves are likely to implement their wishes differently
from patients who let others decide. This is reﬂected in the
typology portrayed in Fig. 2. Because we observed some ﬂuidity
and overlap among the different variants we emphasize that they
should not be seen as ‘‘silos.’’ Identifying how patients want to
make EOL decisions is necessary, but insufﬁcient. One also needs to
address which implementation strategies may best serve the
patient’s decision-making style, especially with respect to effective
decision-making. For example, our ﬁndings suggest that efforts
toward increasing completing advance directives [26–28] are
likely to best serve patients who already made or are ready to make
decisions and are comfortable with formally expressing them, i.e.,
Autonomists, Altruists, and some Authorizers. However, asking
patients to complete advance directives will not be effective for
some Authorizers nor for Absolute Trusters, Avoiders, or even some
Altruists if they prefer verbal communication only. In clinical
practice, completing advance directives is an important accom-
plishment – for patients for whom this is a suitable way to express
their preferred decision-making-style. However, future focus on
improving EOL decision-making for Authorizers, Absolute Trusters,
and Avoiders should shift from trying to increase completion rates
for advance directives toward, as other have suggested [29,30],
preparing patients for EOL decision-making, encouraging clear
guidance through effective verbal communication with surrogates,
identifying legal surrogates, and appointing a preferred agent as
appropriate.
Even though only two patients represented the Avoiders, we
decided to include ‘‘Avoiders’’ as a distinct variant in our model as
we believe that such patients were underrepresented in our focus
groups; by deﬁnition Avoiders would be highly unlikely to
participate in a study discussing EOL decision-making (not
avoiding it), and many practicing physicians are familiar with
such patients. Indeed, among patients who declined to participate,
ten (12%) stated they were not comfortable with the topic.
5.1. Follow-through: execution of decisions
Patients’ selection of their preferred decision-making style is
only the ﬁrst step in EOL decision-making. Implementing decisions
is the crucial next step. Implementation strategies should be
distinguished by whether participants (1) made and clearly
communicated their decisions to those who needed to knowthem, (2) made but did not clearly communicate their decisions to
others, or (3) did not make decisions or even minimally prepare
others to make decisions for them and were thus at risk for
receiving any treatment by default [31].
Autonomists followed through either by completing a living
will that included directions about life-sustaining treatments or by
naming someone as their medical power of attorney and
discussing their wishes with that person, or both. There was a
somewhat ﬂuid transition to the Authorizers, as some would not
speciﬁcally name someone as their power of attorney. If they felt
that the potential for conﬂict was low due to only one or two
potential legal decision makers, they were inclined to only verbally
discuss their wishes and not formally appoint a power of attorney.
Absolute Trusters commonly expressed complete trust in the
person who would be their legal surrogate. They either felt the
person would make ‘‘right’’ decisions because they knew the
person well and trusted her/him; or because the person knew the
patient well and thus would know to do the ‘‘right’’ thing. Their
follow-through consisted only of identifying a power of attorney in
cases where the legal surrogate might not be their preferred one.
Despite consisting of only two patients, the Avoiders were a
heterogenous group. One (Hispanic) Avoider let others decide
quasi-by-default, because he had not thought about things and was
not sure about what he wanted. It was not because he put complete
trust in someone to make the ‘‘right’’ decisions. He had not been
challenged to think about EOL care or he had avoided discussing it,
thus his wife had to decide for him without any guidance. The other
(African American) Avoider similarly let others decide by default,
but he did not appreciate this as letting others decide. Because he
put complete faith in God to make all decisions, any decision-
making on his part – or any other persons’ part – was superﬂuous.
This patient considered deciding anything as unnecessary as all
decisions lie in God’s hands.
5.2. Limitations
Limitations of this qualitative study relate to the number and
composition of the focus groups, an academic setting, and the
mostly male population of a VA Medical Center. Strengths of our
study are that we directly obtained information from patients who
were living with serious life-threatening illnesses, who were well
familiar with EOL decision-making, and that we purposively
included patients with diverse racial/ethnic background. We did
not triangulate our ﬁndings (though many of the same themes
were echoed in two individual interviews testing our guiding
questions) or use key-informants. However, investigators were
racially diverse and from different disciplines (medicine, social
sciences, ethics), and each read transcripts independently before
reaching consensus.
5.3. Conclusion
Our data emphasize that seriously ill patients fell into ﬁve
ethically and clinically distinct variants across race/ethnicity.
Respect for patient autonomy requires recognition of and respect
for these variants and the appropriate implementation strategies
they ensue. Patients’ autonomy can be enhanced by encouraging
patients to make and effectively communicate their decisions,
subject to the limitations on doing so posed by ‘‘Avoiders’’ whose
preferred decision-making style may not allow clinicians to
promote and assist in advance care planning. The physician’s goal
should be to promote effective EOL decision-making with
Autonomists, Altruists, Authorizers, Absolute Trusters, and Avoi-
ders. No one size will ﬁt all patients, whose implementation
strategies may range from completing formal documents to
increasing oral communication with surrogates. Physicians should
U.K. Braun et al. / Patient Education and Counseling 94 (2014) 334–341340judiciously allocate their time in a persistent, respectful, and
supportive effort to engage patients in EOL care planning. Patient-
centered, culturally competent EOL decision-making is a powerful
tool to ensure that patient preferences are truly upheld.
5.4. Practice implications
Physicians have limited time to spend, requiring priorities to be
set. Assisting Autonomists and Altruists to implement EOL
decisions generally will be relatively simple: they have made
decisions and only need to effectively communicate them.
Physicians can assist by providing appropriate paperwork or, for
patients uncomfortable with written documents, strongly encour-
aging patients to discuss their wishes in detail with their legal
surrogate decision maker(s). Surrogates will then be able to report
the already-made decision of the patient, a role that is perceived as
less burdensome [32,33]. Physicians could also facilitate discus-
sions with potential surrogates and clarify to patients who their
legal surrogates are [34].
Assisting some Authorizers may be relatively straightforward
but can sometimes, along with assisting Absolute Trusters, be
considered complex. This is because Authorizers ﬁrst need to make
clearer general value statements before they can effectively
communicate them. Absolute Trusters by deﬁnition let others
decide about their care. They can be strongly encouraged to give
more guidance to their surrogates, moving them to Authorizers or,
if they want to reduce the decision-making burden on surrogates,
Altruists. Often this can be accomplished simply by pointing out
how hard it is to make such important decisions for someone else
without any guidance by that person [31–33,35]. If the patient
allows, physicians might ask the surrogate if he or she would feel
comfortable in making EOL decisions for the patient, and if not,
physicians would need to invest some time to discuss with the
patient and surrogate what might help the surrogate achieve
comfort levels. Any general preferences should be elicited and
recorded. Clinicians would need to encourage increased direct
communication between patient and surrogate and support the
patient by offering to facilitate such conversations. The annual
Medicare wellness visit as recently proposed would have created
an opportunity to accomplish at least a starter conversation with
patients while being reimbursed for doing so [36]. It may be helpful
for patients to know that surrogates may feel burdened by deciding
for others. Some patients view allowing others to make decisions
for them as an act of love or sign of trust and might be quite
surprised to know that not every surrogate welcomes this role.
EOL care planning with Avoiders is difﬁcult as they may be
resistant to interventions to encourage EOL planning, and respect
for autonomy includes allowing patients to not make decisions. It
may sufﬁce to remind such patients of the importance of decision-
making and the major risk of not doing so, receiving life-sustaining
treatment by default, which the patient may or may not want. The
physician can also inform such patients that not making EOL
decisions can result in preventable stress for surrogate decision
makers [32–35]. Avoiders may not welcome such discussions and
they may even be unfruitful and risk harm to the patient–physician
relationship. Clinicians should make every effort to accurately
discern in which variant their patient belongs, and at regular
intervals brieﬂy re-evaluate whether the patient may now be more
open to engage in a conversation about EOL care planning.
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